Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036572 (
seizures
)
80,221
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The family of Tre2-Bub2-Cdc16 (TBC)-domain containing GTPase activating proteins (RABGAPs) is not only known as key regulatorof RAB GTPase activity but also has GAP-independent functions. Rab GTPases are implicated in membrane trafficking pathways, such as vesicular trafficking. We report biallelic loss-of-function variants in
TBC1D2B
, encoding a member of the TBC/RABGAP family with yet unknown function, as the underlying cause of cognitive impairment,
seizures
, and/or gingival overgrowth in three individuals from unrelated families.
TBC1D2B
messenger RNA amount was drastically reduced, and the protein was absent in fibroblasts of two patients. In immunofluorescence analysis, ectopically expressed
TBC1D2B
colocalized with vesicles positive for RAB5, a small GTPase orchestrating early endocytic vesicle trafficking. In two independent
TBC1D2B
CRISPR/Cas9 knockout HeLa cell lines that serve as cellular model of
TBC1D2B
deficiency, epidermal growth factor internalization was significantly reduced compared with the parental HeLa cell line suggesting a role of
TBC1D2B
in early endocytosis. Serum deprivation of
TBC1D2B
-deficient HeLa cell lines caused a decrease in cell viability and an increase in apoptosis. Our data reveal that loss of
TBC1D2B
causes a neurodevelopmental disorder with gingival overgrowth, possibly by deficits in vesicle trafficking and/or cell survival.
...
PMID:Biallelic loss-of-function variants in TBC1D2B cause a neurodevelopmental disorder with seizures and gingival overgrowth. 3262 94